Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

Also called NCT03876119

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 121 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03876119
Main results
  • Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial JAMA, 2022-03-01 DOI, PubMed 35143603, PMC8832304 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03876119. Randomized; quadruple masking; primary purpose treatment. Start 2018-12-05 (actual); primary completion 2021-05-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy
Acronym
CHOICE
Condition
Stroke, Acute
Intervention (Drug)
Intraarterial alteplase
Intervention (Drug)
Placebo
Lead sponsor
Hospital Clinic of Barcelona (class: other)
Collaborator
Fundació La Marató de TV3 (class: other)
Collaborator
Fundacion Clinic per a la Recerca Biomédica (class: other)

Record details

Record id
cardio:ct-nct03876119
Content hash
b8e28ed18effdca53bda9d00f7014cd9b0c3ab9bc0180547d6e2784614df4562